Virtual BPS are short, educational talk sessions meant to bring the latest in peptide research and clinical development to the scientific community.
All talks are vetted by our Scientific Advisory Board for relevance and represent the latest example of therapeutic peptide technologies or related translational research.
The virtual webinar session will consist of two talks followed by Q&A sessions with the audience.
Brian Roberts
Director of Preclinical Immunology
EpiVax, Inc.
Daniela Verthelyi
Chief of the Immunology Lab in the Office of Pharmaceutical Quality Research
CDER, FDA
Mar Albà
Professor
Hospital del Mar Research Institute and ICREA
Sebastiaan van Heesch
Group Leader
Princess Máxima Center for Pediatric Oncology and Oncode Institute
Jakob Fuhrmann
Senior Principal Scientist
Genentech
Maria Soloveychik
CEO
SyntheX
Jessica Kramer
Assistant Professor, Department of Biomedical Engineering
The University of Utah
Yvonne Ware
Associate Director, Manufacturing Operations
BioNTech SE
Gaurav Bhardwaj
Assistant Professor of Medicinal Chemistry
The University of Washington and the Institute for Protein Design
Li Li
Principal Scientist
Merck Research Laboratories
Chengwei Wu
Senior Scientist
Merck Research Laboratories
Chris Bahl
Chief Scientific Officer and Co-founder
AI Proteins
Yu-Shan Lin
Associate Professor
Tufts University
Peter McNamara
Senior Vice President, Head of Research
Tectonic Therapeutic
Sally Wang Liang
Senior Vice President Business Development
PepLib
Tyler Brown
Principal Scientist
i2O Therapeutics
John Gleeson
Senior Scientist, Biopharmaceutics
Merck
Weijun Shen
Director, Metabolic Diseases
CALIBR at Scripps Research
Christian Heinis
Associate Professor
EPFL
